Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Authors :: Daniel J. Landsburg
Matthew Frigault
Michael Heim
Stephen Ronan Foley
Brian T. Hill
Christine M. Ho
Caron A. Jacobson
Samantha Jaglowski
Frederick L. Locke
Ron Ram
Peter A. Riedell
Gunjan L. Shah
Leslie L. Popplewell
Ranjan Tiwari
Stephen Lim
Marta Majdan
Aisha Masood
Marcelo C Pasquini
Cameron J. Turtle
Source :: Blood. 140:1584-1587
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools